论文部分内容阅读
自1982年提出新辅助化疗(术前化疗)的概念,其临床效果和价值已经逐步受到重视。与术后化疗相比,新辅助化疗的优势在于:(1)在肿瘤各级血管和淋巴管未损伤前予以化疗可以大大提高局部组织和器官的药物浓度,抑制和杀伤大量敏感的肿瘤细胞,减少术中、术后有增殖活力的癌细胞发生医
Since 1982 the concept of neoadjuvant chemotherapy (preoperative chemotherapy), its clinical effect and value has gradually been taken seriously. Compared with postoperative chemotherapy, neoadjuvant chemotherapy has the following advantages: (1) Chemotherapy can improve the local tissue and organ drug concentration greatly and inhibit and kill a large number of sensitive tumor cells before chemotherapy at all levels of blood vessels and lymphatic vessels, Reduce intraoperative and postoperative proliferative cancer cells occur doctor